Anthracyline-reduced sequential combination chemotherapy for younger patients with good-prognosis aggressive B-cell non-Hodgkin’s lymphoma. - Schütt, P.; Zimmermann, K.; Derks, C.; Ebeling, P.; Welt, A.; Poser, M.; Hense, J.; Metz, K.; Anhuf, J.; Sandmann, M.; Neise, M.; Moritz, T.; et al. (Journal of Cancer Research & Clinical Oncology, 2009)